CODY MATTINGLY: Open Payments
NPI 1952889685 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 52 payments from 14 companies in 2025. Trend: 2023 $419 · 2024 $895 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $284 |
| ABBVIE INC. | 8 | $186 |
| PFIZER INC. | 9 | $182 |
| Lilly USA, LLC | 6 | $119 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| Novo Nordisk Inc | 5 | $91 |
| Dexcom, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Exact Sciences Corporation | 2 | $43 |
| Amgen Inc. | 2 | $39 |
Products named: FARXIGA, MOUNJARO, UBRELVY, NURTEC ODT, TRELEGY ELLIPTA, QULIPTA, Wegovy, Dexcom G6 Transmitter.
Industry payments across ID — which companies pay providers there.
